Literature DB >> 11170636

Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships.

N R Guz1, F R Stermitz, J B Johnson, T D Beeson, S Willen, J Hsiang, K Lewis.   

Abstract

Although some progress has been reported on structure-activity relationships (SARs) for inhibitors of mammalian P-glycoprotein MDR efflux pumps, there is almost nothing in the literature regarding SARs for inhibitors of any bacterial efflux pump. Indeed, only a few of these have been described. Our discovery of a potent naturally occurring flavonolignan inhibitor of the NorA MDR pump of Staphylococcus aureus provided a structural foundation upon which SARs could be assessed via synthetic analogues. Several flavonolignans were prepared which proved to have greater potency than the natural isolate, 5'-methoxyhydnocarpin-D, while others showed decreased potency. Surprisingly, some simple alkylated flavones also were quite active MDR pump inhibitors. Variability of activity among the compounds tested was sufficient so that at least some SARs could be postulated and compared with those known for P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170636     DOI: 10.1021/jm0004190

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Inhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 4'-hydroxyflavone and enhancement of fungicide activity.

Authors:  Sven Reimann; Holger B Deising
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  In silico screening for antibiotic escort molecules to overcome efflux.

Authors:  Sheikh S Rahman; Ivana Simovic; Simon Gibbons; Mire Zloh
Journal:  J Mol Model       Date:  2011-02-08       Impact factor: 1.810

4.  Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal).

Authors:  Emily R Britton; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2017-11-01       Impact factor: 4.050

5.  Mechanistic study of the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle.

Authors:  Hanan S Althagafy; Maria Elena Meza-Aviña; Nicholas H Oberlies; Mitchell P Croatt
Journal:  J Org Chem       Date:  2013-07-22       Impact factor: 4.354

6.  Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.

Authors:  Glenn W Kaatz; Varsha V Moudgal; Susan M Seo; Jette E Kristiansen
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mastura Mohtar; Saiful Azmi Johari; Abdul Rashid Li; Mazurah Mohamed Isa; Shuhaimi Mustafa; Abdul Manaf Ali; Dayang Fredalina Basri
Journal:  Curr Microbiol       Date:  2009-05-28       Impact factor: 2.188

8.  Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.

Authors:  Joseph I Ambrus; Michael J Kelso; John B Bremner; Anthony R Ball; Gabriele Casadei; Kim Lewis
Journal:  Bioorg Med Chem Lett       Date:  2008-07-02       Impact factor: 2.823

9.  Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates.

Authors:  Monique Malléa; Abdallah Mahamoud; Jacqueline Chevalier; Sandrine Alibert-Franco; Pierre Brouant; Jacques Barbe; Jean-Marie Pagès
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

10.  6,7-dihydroxyflavone dramatically intensifies the susceptibility of methicillin-resistant or -sensitive Staphylococcus aureus to beta-lactams.

Authors:  Youichi Sato; Hirofumi Shibata; Naokatu Arakaki; Tomihiko Higuti
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.